Drug Resistant Models

Comprehensive portfolio of drug resistant models representing clinically relevant mechanisms of resistance:

  • 10+ cancer types
  • 25+ key targets
  • 30+ leading drugs
  • 100+ resistant models
  • Extensive validation data

Our capabilities include cutting-edge bioinformatics and analytical techniques to enable a clear and in-depth understanding of resistance mechanisms

View our AACR poster describing the establishment of a wide panel of drug-induced resistant tumor models

Leverage our extensive panel of CDK4/6 inhibitor resistant breast cancer models



Drug Resistant Models

Download

← Return to Resources

Related Content

NK cells are effector innate lymphoid cells (ILCs) that do not require antigen-specific priming. NK cells are not only killer...

VIEW RESOURCE

Join WuXi AppTec at IMMUNOLOGY2024™. For this year’s annual meeting of the American Association of Immunologists (AAI), WuXi Biology has...

VIEW RESOURCE
← View all Immunology Resources
× peptide, amino acid

Contact An Expert Today!